{"article_title": "New Push Ties Cost of Drugs to How Well They Work", "article_keywords": ["set", "seeking", "drugs", "yearsome", "work", "workthe", "deals", "cost", "rising", "socalled", "scripts", "push", "ties", "pricing"], "article_url": "http://www.wsj.com/articles/new-push-ties-cost-of-drugs-to-how-well-they-work-1432684755", "article_text": "Express Scripts Holding Co., a large manager of prescription-drug benefits for U.S. employers and insurers, is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.\n\nThe effort is part of a growing push for so-called pay-for-performance deals amid complaints about the rising price of medications, some of which cost more than $100,000 per patient a year.\n\nSome...", "article_metadata": {"article.template": "snippet", "article.created": "2015-05-26T23:59:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Express Scripts is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.", "creator": "@Loftus", "image": {"alt": "Express Scripts is seeking to tie the price of some cancer drugs to how well they work", "identifier": "https://si.wsj.net/public/resources/images/OG-AE685_201505_D_20150526185901.jpg"}, "title": "New Push Ties Cost of Drugs to How Well They Work", "site": "@WSJ", "card": "summary_large_image"}, "al": {"ios": {"url": "wsj://launch?articleid=SB12013707085963353461804581009803147434360&headline=Express%20Scripts%20is%20seeking%20to%20tie%20the%20price%20of%20some%20cancer%20drugs%20to%20how%20well%20they%20work&weburl=http://www.wsj.com/articles/SB12013707085963353461804581009803147434360"}}, "page.site.product": "WSJ", "keywords": "cancer drugs,cancer drug trials,cost of cancer drugs,drug costs,indication-specific pricing,pay for performance,rising costs of drugs,Express Scripts Holding,ESRX,Leschly%2C%20Nick,research,development,corporate,industrial news,cancer,political,general news,health,medical conditions,pharmaceuticals,health care,life sciences,specialized drugs,medications,healthcare support services,pharmacy benefit management", "news_keywords": "cancer drugs,cancer drug trials,cost of cancer drugs,drug costs,indication-specific pricing,pay for performance,rising costs of drugs,Express Scripts Holding,ESRX,Leschly%2C%20Nick", "article.headline": "Express Scripts is seeking to tie the price of some cancer drugs to how well they work", "cXenseParse": {"candybar": {"image": "https://si.wsj.net/public/resources/images/OG-AE685_201505_E_20150526185901.jpg"}, "poptart": {"image": "https://si.wsj.net/public/resources/images/OG-AE685_201505_D_20150526185901.jpg"}}, "description": "Express Scripts is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB12013707085963353461804581009803147434360&headline=Express%20Scripts%20is%20seeking%20to%20tie%20the%20price%20of%20some%20cancer%20drugs%20to%20how%20well%20they%20work&weburl=http://www.wsj.com/articles/SB12013707085963353461804581009803147434360", "user.type": "nonsubscriber", "article.page": "Health Care", "article.emb": "video_emb", "page.content.format": "responsive", "article.summary": "Express Scripts is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.", "page.site": "wsj", "testkeys": "C", "article.published": "2015-05-26T23:59:00.000Z", "dj.asn": "i-e963", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "video_count": 1, "embed_count": 1, "word_count": 1368, "internal_link_count": 3, "image_count": 2}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Express Scripts is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.", "title": "New Push Ties Cost of Drugs to How Well They Work", "url": "http://www.wsj.com/articles/new-push-ties-cost-of-drugs-to-how-well-they-work-1432684755", "image": {"width": 359, "identifier": "https://si.wsj.net/public/resources/images/OG-AE685_201505_E_20150526185901.jpg", "height": 239}, "locale": "en_US", "type": "article"}, "author": "Peter Loftus", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "New Push Ties Cost of Drugs to How Well They Work", "article.type": "Health", "article.id": "SB12013707085963353461804581009803147434360", "user.exp": "default", "article.updated": "2015-05-26T23:59:00.000Z"}, "_id": "\"57477af46914bd0286fd9a2d\"", "article_summary": "Express Scripts Holding Co., a large manager of prescription-drug benefits for U.S. employers and insurers, is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.\nThe effort is part of a growing push for so-called pay-for-performance deals amid complaints about the rising price of medications, some of which cost more than $100,000 per patient a year."}